Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC

CAMBRIDGE, Mass., Nov. 27, 2023 /PRNewswire/ -- On November 22, 2023, the board of directors of Theseus Pharmaceuticals, Inc. received an unsolicited joint letter from funds and persons...

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Concentra Biosciences ,Josh Rappaport ,Neither The Company ,Theseus Pharmaceuticals ,Foresite Capital ,Board Of Theseus Pharmaceuticals Inc ,Exchange Commission ,Nasdaq ,Orbimed Advisors ,Theseus Pharmaceuticals Inc ,Tang Capital Partners ,Theseu Board ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Report ,Markets ,